Skip to main content
SpringerLink
Log in

Adjuvant Chemotherapy

  • Chapter
  • First Online:
Liver Metastases

  • 901 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55: 10–30.

    Article  PubMed  Google Scholar 

  2. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994; 343: 1405–10.

    Article  PubMed  CAS  Google Scholar 

  3. Nordlinger B, Jaeck D, Guiguet M, et al. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D, eds. Treatment of Hepatic Metastases of Colorectal Cancer. Paris: Springer-Verlag; 1992: 129–146.

    Chapter  Google Scholar 

  4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230: 309–18.

    Article  PubMed  CAS  Google Scholar 

  5. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989; 7: 1646–54.

    PubMed  CAS  Google Scholar 

  6. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomized trial. J Clin Oncol. 1992; 10: 1112–8.

    PubMed  CAS  Google Scholar 

  7. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994; 344: 1255–60.

    Article  PubMed  CAS  Google Scholar 

  8. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non resectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000; 18: 243–54.

    PubMed  CAS  Google Scholar 

  9. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases. Ann Surg. 1998; 228: 756–62.

    Article  PubMed  CAS  Google Scholar 

  10. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999; 341: 2039–48.

    Article  PubMed  CAS  Google Scholar 

  11. Kemeny MM, Adak S, Gray B, et al Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol. 2002; 20: 1499–1505.

    Article  PubMed  Google Scholar 

  12. Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005; 23: 4881–7.

    Article  PubMed  CAS  Google Scholar 

  13. Lopez-Ladron A, Salvador AJ, Bernabe R, et al. Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol. 2003; 22: 373 (abstr 1497).

    Article  Google Scholar 

  14. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006; 24: 4976–82.

    Article  PubMed  CAS  Google Scholar 

  15. Langer B, Bleiberg H, Labianca R. Fluorouracil (FU) plus 1-leucovorin (1-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. J Clin Oncol. 2002; 20: 149a (abstr 592).

    Google Scholar 

  16. Mitry E, Fields A, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials. J Clin Oncol. 2006; 24: 18S (abst 3524).

    Article  Google Scholar 

  17. Tanaka K, Adam R, Shimada H, et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg. 2003; 90: 963–9.

    Article  PubMed  CAS  Google Scholar 

  18. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2005; 23: 2038–48.

    Article  PubMed  CAS  Google Scholar 

  19. Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003; 7: 109–15.

    Article  PubMed  Google Scholar 

  20. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 2004; 240: 1052–61.

    Article  PubMed  Google Scholar 

  21. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006; 24: 3939–45.

    Article  PubMed  Google Scholar 

  22. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004; 15: 460–6.

    Article  PubMed  CAS  Google Scholar 

  23. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003; 7: 1034–44.

    Article  PubMed  Google Scholar 

  24. Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005; 200: 845–53.

    Article  PubMed  Google Scholar 

  25. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol. 2005; 23: 9073–8.

    Article  PubMed  CAS  Google Scholar 

  26. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006; 243: 1–7.

    Article  PubMed  Google Scholar 

  27. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006; 24: 2065–72.

    Article  PubMed  CAS  Google Scholar 

  28. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006; 24: 4983–90.

    Article  PubMed  CAS  Google Scholar 

  29. Nordlinger B, Benoist S. Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol. 2006; 24: 4954–5.

    Article  PubMed  Google Scholar 

  30. Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer. 1998; 77: 2008–11.

    Article  PubMed  CAS  Google Scholar 

  31. Nordlinger B, Sorbye H, Debois M, et al. Feasibility and risks of pre-operative chemotherapy with FOLFOX 4 and surgery for resectable colorectal liver metastases. Interim results of the EORTC intergroup randomized phase III study 4093. J Clin Oncol. 2005; 23: 253 s (abstr 3528).

    Google Scholar 

  32. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350: 2335–42.

    Article  PubMed  CAS  Google Scholar 

  33. D’Angelica M, Kornprat P, Gonen M, et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study. Ann Surg Oncol. 2006; 14: 759–65.

    Article  PubMed  Google Scholar 

  34. Gruenberger T, Sorbye H, Debois M, et al. Tumor response to pre-operative chemotherapy with FOLFOX-4 for resectable colorectal cancer liver metastases. Interim results of EORTC intergroup randomized phase III study 40983. J Clin Oncol. 2006; 24: 146s (abstr 3500).

    Article  Google Scholar 

  35. Wein A, Riedel C, Bruckl W, et al. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology. 2003; 64: 131–8.

    Article  PubMed  Google Scholar 

  36. Taieb J, Artru P, Paye F, et al. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. J Clin Oncol. 2005; 23: 502–9.

    Article  PubMed  CAS  Google Scholar 

  37. Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC Intergroup randomized phase III trial study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol. 2007; 25: 18S (abstr LBA5).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor of Surgery, Department of Digestive Surgery and Oncology, Ambroise Pare Hospital, Boulogne, France

    Christophe Penna

Authors
  1. Christophe Penna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard Nordlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, Dept. Surgical Oncology, University of Texas, Holcombe Blvd. 1515, Houston, 77030, Texas, USA

    Jean-Nicolas Vauthey

  2. São Paulo, Faculdade de Medicina da, Universidade de São Paulo,, Instituto do Cancer do Estado de, Ave Dr Arnaldo 251, São Paulo, 01246-000, São Paulo, Brazil

    Paulo M. Hoff

  3. University of Liverpool, St Helens Teach, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  4. Center for Digestive Diseases, University Hospital Aintree, Lower Lane, Liverpool, L9 7AL, United Kingdom

    Graeme J. Poston

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London

About this chapter

Cite this chapter

Penna, C., Nordlinger, B. (2009). Adjuvant Chemotherapy. In: Vauthey, JN., Hoff, P., Audisio, R., Poston, G. (eds) Liver Metastases. Springer, London. https://doi.org/10.1007/978-1-84628-947-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-947-7_8

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-946-0

  • Online ISBN: 978-1-84628-947-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation